Craft

ClexBio

Total Funding

$2.2 M

ClexBio Summary

Company Summary

Overview
ClexBio (also known as Nordovo Biosciences AS) is a biotech company creating solutions for tissue engineering and single-cell techniques by combining bio-fabrication approaches with its proprietary hydrogel technology CLEX. It develops Competitive Ligand Exchange X-Linking (CLEX) technology to manipulate delicate living cells at the micro-scale, a prerequisite for recreating functional biological tissue architectures in the lab. ClexBio engineers patient-specific tissue transplants for preclinical and clinical applications by combining bio-fabrication tools, bio-materials, and living human cells.
Type
Private
Status
Active
Founded
2018
HQ
Oslo, NO | view all locations
Website
https://www.clexbio.com/
Cybersecurity rating
Sectors

Table of Contents

LocationsView all

2 locations detected

  • Oslo, Oslo HQ

    Norway

    Rathkes gate 4

  • Oslo, Oslo

    Norway

    Forskningsparken Aksjeselskap, Gaustadalléen 21

Footer menu